It is demonstrated that lifelong cumulative antimicrobial immune history generates reproducible serological signatures associated with healthy aging and cancer status, and supports the potential value of comprehensive serological profiling for future cancer risk stratification.
Abstract
A viral exposure signature (VES) has previously been shown to predict the development of hepatocellular carcinoma (HCC) in at-risk individuals through comprehensive serological profiling using the VirScan platform. Whether cumulative antimicrobial immune histories are associated with cancer status across multiple malignancies remains unknown. We applied high-throughput VirScan systems serology to characterize antibody reactivities against a comprehensive microbial peptide library in 359 participants, including 172 patients with cancer and 187 healthy individuals. To account for age-related immune remodeling, healthy participants were stratified into adults ( < 70 years) and exceptionally healthy elderly individuals ( > 80 years, including nonagenarians and centenarians). Differential Pan-viral Seroreactivity Profiles (DPSPs) were identified through an unbiased statistical workflow combining differential class comparison, feature selection, predictive modeling, cross-validation, and receiver operating characteristic (ROC) curve analysis. Distinct DPSPs discriminated healthy individuals from patients with cancer. The identified signatures comprised antibody reactivities against peptides derived predominantly from persistent herpesviruses, acute respiratory viruses and, consistently across multiple comparisons, human respiratory syncytial virus (HRSV). Remarkably, healthy elderly individuals generally exhibited higher antibody titers than patients with cancer, whereas healthy adults showed the opposite pattern. These differential serological signatures supported accurate class prediction in several comparisons, indicating that cumulative antimicrobial immune histories differ according to health status after accounting for physiological immune aging. Our findings demonstrate that lifelong cumulative antimicrobial immune history generates reproducible serological signatures associated with healthy aging and cancer status. Although the present cross-sectional study does not establish causal biological protection, it identifies hypothesis-generating biomarkers that warrant validation in independent prospective cohorts and supports the potential value of comprehensive serological profiling for future cancer risk stratification.
Introduction Long COVID (LC) is characterized by persistent and, often, disabling symptoms, yet its biological basis remains unclear. Multiple mechanisms, including immune dysregulation, endothelial dysfunction, and persistence of SARS-CoV-2 components, have been proposed, although it is unknown whether these define di...
F. Muñoz-López, Marissa Flores-Santamaría, R. Santano et al.· Frontiers in Immunology· 0 citations
Epstein-Barr virus (EBV) infects most adults worldwide and usually persists without symptoms, yet in some individuals it is associated with malignancies such as nasopharyngeal carcinoma (NPC). How antibody responses to specific regions of EBV proteins differ between healthy individuals and patients with NPC remains inc...
Pigs are crucial as food sources, biomedical models, and reservoirs of some zoonotic viruses, yet their comprehensive viral exposure history remains poorly understood. Here, we developed SwiVirScan, a T7 phage display-based serological platform containing 36,416 peptides derived from 140 known swine-associated viruses....
Understanding the interplay between the immune system's dynamics and the natural aging process is crucial for developing potential strategies to mitigate age-related health challenges. Here, we investigated how immunophenotypic profiles vary with the natural aging process, daily practices, and physiological characteris...
Yi-Yang Li, Bo-Qian Wang, Xu-Ling Han et al.· Analytical Chemistry· 0 citations
The SLE autoantibody landscape is expanded, disease activity associated autoreactivities are identified and insight linking EBV-driven immunity to epitope-specific autoimmunity in lupus is insight.
C. Hurabielle, Yu-Tong V. Wang, B. Castillo-Rojas et al.· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.